Shin-Ichiro Umemura Selected Research

Shin-Ichiro Umemura Research Topics

12	Neoplasms (Cancer) 05/2020 - 09/2002
4	Sarcoma 180 02/2011 - 03/2004
2	Glioma (Gliomas) 07/2011 - 03/2009
1	Hyperthermia 01/2018
1	Body Weight (Weight, Body) 03/2009
1	Brain Neoplasms (Brain Tumor) 03/2009
1	Leukemia 10/2006
1	Urinary Tract Infections (Urinary Tract Infection) 08/2006
1	Lymphoma (Lymphomas) 03/2006
1	Carcinoma (Carcinomatosis) 01/2004
1	Drug-Related Side Effects and Adverse Reactions 12/2002
1	Shock 12/2002

2	CarbonIBA 06/2016 - 08/2013
2	FullerenesIBA 06/2016 - 08/2013
2	Rose BengalIBA 09/2010 - 03/2009
2	Phosphates (Orthophosphate)IBA 09/2010 - 03/2004
2	Photosensitizing Agents (Photosensitizers)IBA 03/2009 - 03/2009
2	GalliumIBA 11/2007 - 09/2004
2	PorphyrinsIBA 11/2007 - 09/2004
2	ATX 70IBA 11/2007 - 09/2004
2	Trypan Blue FDA Link 03/2006 - 03/2004
1	AcidsIBA 07/2011
1	Talaporfin (talaporfin sodium)IBA 02/2011
1	SuspensionsIBA 02/2011
1	13,17- bis(1- carboxyethyl)- 8- (2- (2,4- dichlorophenylhydrazono)ethylidene)- 3- ethenyl- 7- hydroxy- 2,7,12,18- tetramethylchlorinIBA 06/2010
1	salicylhydroxamic acid (SHAM)IBA 03/2009
1	antineoplaston A10 (A 10)IBA 03/2009
1	SHU 508 (Levovist)IBA 10/2006
1	Contrast MediaIBA 10/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2006
1	Proteins (Proteins, Gene)FDA Link 03/2006
1	Complementary DNA (cDNA)IBA 03/2006
1	Messenger RNA (mRNA)IBA 03/2006
1	Coloring Agents (Dyes)IBA 03/2006
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 03/2004
1	Saline SolutionIBA 03/2004
1	chloroaluminum tetrasulfophthalocyanineIBA 01/2004
1	Antineoplastic Agents (Antineoplastics)IBA 12/2002

11	Therapeutics 05/2020 - 09/2002
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2018
1	Craniotomy 03/2009
1	Intravenous Injections 03/2009
1	Ultrasonic Therapy 03/2009
1	Aftercare (After-Treatment) 08/2006